Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Pinto, Y. Galea, C. Martí, B. Muñoz, M. Sagales, Y. Oujja, J. Tarrega, E. Barbeta (Granollers, Spain). Impact of quinolones consume in Streptococcus pneumoniae resistance. Eur Respir J 2010; 36: Suppl. 54, 5188

Member's Comments

No comment yet.

Related content which might interest you: Quinolones consume and streptococcus pneumoniae antibiotic resistance Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 Emergence of penicillin resistant Streptococcus pneumoniae in Pakistan Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005 CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Resistance to penicillin among the Streptococcus pneumoniae in Turkey Source: Eur Respir J 2001; 18: 436 Year: 2001 Increasing global resistance to penicillin, macrolides and other antimicrobials among isolates of Streptococcus pneumoniae: susceptibility data from three years of the PROTEKT surveillance study Source: Eur Respir J 2003; 22: Suppl. 45, 486s Year: 2003 Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Resistance of Streptococcus pneumoniae to penicillin, azitromycin, ciprofloxacyn and ceftriaxon Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Therapeutic efficacy of macrolides, minocycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections Source: Eur Respir J 2002; 20: 3S-8S Year: 2002 Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Resistance of respiratory tract Streptococcus pneumoniae strains Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Impact of antibiotic consumption in the evolution of respiratory pseudomonas antibiotic resistance Source: Eur Respir J 2006; 28: Suppl. 50, 787s Year: 2006 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial Source: Eur Respir J 2004; 23: 921-926 Year: 2004 Factors associated with colonization and infection by Carbapenem Resistant Enterobacteriaceae Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010